Actions of epoxygenase metabolites on the preglomerular vasculature.

Journal of the American Society of Nephrology : JASN
J D ImigJ R Falck

Abstract

Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow. This study examined the preglomerular actions of various epoxyeicosatrienoic acids (EET). By use of the in vitro blood-perfused juxtamedullary nephron preparation, interlobular and afferent arteriolar diameter responses to 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET were determined. Diameters of interlobular and afferent arterioles preconstricted with 0.5 microM norepinephrine averaged 24 +/- 1 microns (N = 27) and 17 +/- 1 microns (N = 32), respectively, at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diameters of the interlobular and afferent arterioles. At a dose of 100 nM, 11,12-EET increased the diameters of the interlobular and afferent arterioles by 18 +/- 2% (N = 10) and 20 +/- 3% (N = 9), respectively. The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diameters of the interlobular and afferent arterioles. 14,15-EET had a much smaller effect and increased the diameters of the these vessels by 10%; 8,9-EET did not significantly affect vascular diameters. In con...Continue Reading

Citations

Feb 27, 2001·Current Opinion in Nephrology and Hypertension·J C McGiff, J Quilley
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Motoaki MiyazonoEthan P Carter
May 16, 2021·Experimental & Molecular Medicine·Hak Su KimJin Woo Song
Sep 26, 2000·The Journal of Biological Chemistry·C J SinalF J Gonzalez
Nov 9, 2000·Clinical and Experimental Pharmacology & Physiology·R J RomanM Alonso-Galicia
Feb 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Benjamin B DavisRobert H Weiss
Oct 26, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·K KohaguraS Ito
Dec 2, 2006·Experimental Biology and Medicine·Hui HuangMong-Heng Wang
Mar 23, 2004·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Ahmed E EnayetallahDavid F Grant
Nov 25, 2003·Prostaglandins & Other Lipid Mediators·David SacerdotiJohn C McGiff
Jun 19, 2004·Current Opinion in Nephrology and Hypertension·Albert SarkisRichard J Roman
Jun 24, 2004·The Journal of Biological Chemistry·Houli JiangPatrick Y-K Wong
Aug 26, 2004·American Journal of Physiology. Renal Physiology·Xuemei WangRodger Loutzenhiser
Sep 4, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Xueying ZhaoJohn D Imig
Sep 24, 2004·American Journal of Physiology. Renal Physiology·Yiqiang ZhouMong-Heng Wang
Apr 16, 2004·The Journal of Pharmacology and Experimental Therapeutics·Tracy C DeLozierJoyce A Goldstein
Nov 24, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·E RousseauSonia Proteau
Dec 3, 2008·Hypertension·YiLin RenOscar A Carretero
Nov 27, 2009·Stroke; a Journal of Cerebral Circulation·Julie LeeBørge G Nordestgaard
Apr 9, 2005·American Journal of Physiology. Renal Physiology·Elvira L LiclicanMairead A Carroll
Mar 17, 2005·The Journal of Pharmacology and Experimental Therapeutics·Adebayo O Oyekan
Jul 15, 2005·American Journal of Physiology. Renal Physiology·Albert SarkisRichard J Roman
Aug 23, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Xiang FangArthur A Spector
Oct 14, 2005·The Journal of Pharmacology and Experimental Therapeutics·Benjamin B DavisRobert H Weiss
Feb 16, 2006·American Journal of Physiology. Renal Physiology·Mairéad A CarrollJohn C McGiff
Aug 12, 2005·American Journal of Physiology. Renal Physiology·John D Imig
Apr 26, 2006·European Journal of Clinical Investigation·B T LarsenO A Hatoum
Feb 28, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Xueying ZhaoJohn D Imig
Jun 27, 2006·American Journal of Physiology. Heart and Circulatory Physiology·David SacerdotiNader G Abraham
Jun 13, 2006·Clinical Science·John D Imig

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.